CMCSA(CMCSA)
CMCSA
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $121.80B | $120.21B | $123.13B | $121.73B | $125.52B |
| Low | $120.56B | $118.89B | $123.00B | $119.88B | $123.61B |
| High | $123.10B | $123.33B | $123.26B | $123.97B | $127.84B |
| EBITDA Avg | $55.65B | $54.92B | $56.26B | $55.62B | $57.35B |
| Low | $55.09B | $54.32B | $56.20B | $54.77B | $56.48B |
| High | $56.25B | $56.35B | $56.32B | $56.65B | $58.41B |
| EBIT Avg | $38.46B | $37.96B | $38.88B | $38.44B | $39.64B |
| Low | $38.07B | $37.54B | $38.84B | $37.85B | $39.03B |
| High | $38.87B | $38.94B | $38.92B | $39.15B | $40.37B |
| Net Income Avg | $13.06B | $13.50B | $15.24B | $16.43B | $18.65B |
| Low | $12.03B | $12.35B | $13.55B | $16.10B | $18.28B |
| High | $14.10B | $14.65B | $16.94B | $16.82B | $19.10B |
| EPS Avg | $3.51 | $3.78 | $4.18 | $4.52 | $5.13 |
| Low | $3.31 | $3.40 | $3.73 | $4.43 | $5.03 |
| High | $3.88 | $4.03 | $4.66 | $4.63 | $5.25 |
| Analysts (Rev / EPS) | 18 / 15 | 17 / 15 | 15 / 10 | 11 / 4 | 7 / 4 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $29.23B | $30.00B | $31.01B | $29.58B | $29.18B | $29.66B | $30.96B | $29.95B |
| Low | $29.07B | $29.75B | $30.51B | $29.10B | $28.71B | $29.18B | $30.45B | $29.46B |
| High | $29.51B | $30.28B | $31.46B | $30.01B | $29.60B | $30.09B | $31.40B | $30.38B |
| EBITDA Avg | $13.36B | $13.71B | $14.17B | $13.52B | $13.33B | $13.55B | $14.15B | $13.68B |
| Low | $13.28B | $13.59B | $13.94B | $13.30B | $13.12B | $13.33B | $13.91B | $13.46B |
| High | $13.48B | $13.83B | $14.37B | $13.71B | $13.52B | $13.75B | $14.35B | $13.88B |
| EBIT Avg | $9.23B | $9.47B | $9.79B | $9.34B | $9.21B | $9.37B | $9.78B | $9.46B |
| Low | $9.18B | $9.39B | $9.63B | $9.19B | $9.06B | $9.21B | $9.62B | $9.30B |
| High | $9.32B | $9.56B | $9.93B | $9.48B | $9.35B | $9.50B | $9.91B | $9.59B |
| Net Income Avg | $3.50B | $3.74B | $2.62B | $2.93B | $3.71B | $3.94B | $2.96B | $3.63B |
| Low | $3.29B | $3.59B | $2.57B | $2.87B | $3.64B | $3.86B | $2.90B | $3.56B |
| High | $3.68B | $3.95B | $2.67B | $2.98B | $3.78B | $4.01B | $3.02B | $3.70B |
| EPS Avg | $0.97 | $1.03 | $0.73 | $0.81 | $1.03 | $1.09 | $0.82 | $1.00 |
| Low | $0.91 | $0.99 | $0.71 | $0.79 | $1.01 | $1.07 | $0.80 | $0.98 |
| High | $1.02 | $1.09 | $0.74 | $0.82 | $1.05 | $1.11 | $0.83 | $1.02 |
| Analysts (Rev / EPS) | 14 / 13 | 13 / 12 | 6 / 10 | 6 / 5 | 6 / 5 | 6 / 5 | 6 / 5 | 5 / 7 |